# The Medicines (Products for Human Use-Fees) Regulations 2008, Paragraph 5: Marketing authorizations


Unless paragraphs 6 to 10 apply, the fee payable under regulation 31(3) in connection with the holding of a marketing authorization relating to a medicinal product of a kind described in Column 1 of the following Table is the applicable fee specified in the corresponding entry in Column 2 of that Table.
Table 1
Column 1
Kind of product
Column 2
Fee payable
1. New Active Substance
£21,108
2. Other kinds of Medicinal Product—
(a)
Any product (not being a derivative of a new active substance) in respect of which a marketing authorization has been granted in consequence of a complex application submitted on or after 1st April 1989
£8,692
(b)
Prescription Only Medicine
(i)
Standard Fee
£2,174
(ii)
Reduced Rate Fee
£1,085
(iii)
Maintenance Fee
£352
(c)
Pharmacy Medicine
(i)
Standard Fee
£951
(ii)
Reduced Rate Fee
£476
(iii)
Maintenance Fee
£176
(d)
General Sale List Medicine
(i)
Standard Fee
£393
(ii)
Reduced Rate Fee
£195
(iii)
Maintenance Fee
£85
(e)
Herbal Remedy
£108
(f)
National homoeopathic product
£77
(g)
Homoeopathic or anthroposophic product which is the subject of a licence of right
£70

---
Source: https://www.legislation.gov.uk/uksi/2008/552/schedule/3/paragraph/5 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2008/schedule-3/paragraph-5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.